2008
DOI: 10.1667/rr1148.1
|View full text |Cite
|
Sign up to set email alerts
|

Inactivation of Thrombomodulin by Ionizing Radiation in a Cell-Free System: Possible Implications for Radiation Responses in Vascular Endothelium

Abstract: Background-Normal tissue radiation injury is associated with loss of vascular thromboresistance, notably because of deficient levels of endothelial thrombomodulin (TM). TM is located on the luminal surface of most endothelial cells and serves critical anticoagulant and anti-inflammatory functions. Chemical oxidation of a specific methionine residue (Met388) at the thrombin-binding site in TM reduces its main functional activity, i.e., the ability to activate protein C. We examined whether exposure to ionizing … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0

Year Published

2009
2009
2020
2020

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 15 publications
(11 citation statements)
references
References 44 publications
(40 reference statements)
0
11
0
Order By: Relevance
“…Thrombomodulin has been included in this study, for its function as a crucial player in the maintenance of the haemostatic balance. It is involved in vascular thromboresistance and anticoagulant homeostasis [ 26 28 ] but may also affect the expression of adhesion molecules [ 29 ]. During radiotherapy, dose-dependent increases of plasma TM in cancer patients were observed and it has been suggested as a marker of radiation-induced endothelial cell injury [ 30 ].…”
Section: Introductionmentioning
confidence: 99%
“…Thrombomodulin has been included in this study, for its function as a crucial player in the maintenance of the haemostatic balance. It is involved in vascular thromboresistance and anticoagulant homeostasis [ 26 28 ] but may also affect the expression of adhesion molecules [ 29 ]. During radiotherapy, dose-dependent increases of plasma TM in cancer patients were observed and it has been suggested as a marker of radiation-induced endothelial cell injury [ 30 ].…”
Section: Introductionmentioning
confidence: 99%
“…Deficiencies in endothelial TM are associated with a variety of disease states, including vascular diseases [ 16 ], graft- versus -host disease [ 17 ] and infectious diseases [ 18 ], and therapeutic use of recombinant TM or APC reduces mortality in patient with disseminated intravascular coagulation and/or severe sepsis [ 19 21 ]. Moreover, ionizing radiation reduces TM expression and function, both indirectly and directly [ 22 , 23 ], and radiation-induced loss of TM appears to be involved in both early and delayed radiation toxicity [ 3 , 24 ]. Conversely, systemic administration of recombinant TM or APC protects mice from lethality partly by accelerating recovery of hematopoietic cells [ 4 ].…”
Section: Discussionmentioning
confidence: 99%
“…Exposure to 1.8–80 Gy 137 Cs γ-radiation caused oxidation of Met388 at the thrombin-binding site of TM, leading to radiation dose-dependent impairment of the TM-thrombin complex formation, and insufficient activation of protein C (Ross et al 2008). Irradiation leads to changes in levels of coagulation factors (TM, factors II, V, VII, VIII, IX, X, XI and XII) and soluble fibrin, increasing blood clotting times, haemorrhage, and microvascular fibrin clots in lung, liver and kidneys of irradiated animals (Krigsfeld and Kennedy 2013; Krigsfeld et al 2012, 2013).…”
Section: Radiation-induced Immune Mediatorsmentioning
confidence: 99%